On the other hand, DHPS expression appeared to correlate positively with sensitivity to other agents, such as NAMPT, BCL2, and MDMX inhibitors (Fig. 5b), indicating that DHPS level can be used as a predictive biomarker for response to several different anti-cancer agents. This evidence concerns the gene BCL2 and cancer.